Researchers at the Medical University of South Carolina, led by Foster Olive, Ph.D., have discovered that a research drug called MTEP (3-((2-methyl-4-thiazolyl)ethynyl)pyridine) helped laboratory rodents kick their methamphetamine habit and decreased their chance of relapse. The results of the study earned first article in the March 2009 issue of Neuropsychopharmacology.
Read More: New Evidence Supports Idea That Targeting Brain Proteins May Help Treat Meth Addiction
